Vernal

New York, United States Founded: 2010 • Age: 16 yrs Acquired By Orioninc
A fragment and structure-based drug discovery platform is provided.
Request Access

About Vernal

Vernal is a company based in New York (United States) founded in 2010 was acquired by Orioninc in March 2017.. Vernal operates in a competitive market with competitors including Aqemia, NTxBio, Nimble Therapeutics, Applied BioMath and IMIDomics, among others.

  • Headquarter New York, United States
  • Sectors
    Healthcare
  • Email
    ***********
  • Phone
    *********
  • Website
    *********
  • Social
    *********
Operational Areas
Healthcare → Biotechnology, Genomics & Life Sciences Research
Key Metrics
  • Annual Revenue
  • Net Profit
  • EBITDA
  • Latest Funding Round
  • Investors
    Orioninc

    & 1 more

  • Employee Count
    Employee Count
  • Acquired by
    Orioninc

    (Mar 23, 2017)

Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • Full access to every database India & global coverage, advanced filters and rich profile details
  • Always-on access from your team account Single premium plan for everything you see on the portal

Funding Insights of Vernal

Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Jan, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Investors in Vernal

Vernal has secured backing from 2 investors, including venture fund investors. Prominent investors backing the company include Orioninc and Potomac Equity Partners. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.

All
Venture Fund
Investor Description Founded Year Domain Location
Potomac Equity Partners is engaged in private equity investments.
Founded Year Domain Location
Provider of AI, data analytics, application development and IT security services
Founded Year Domain Location
Investor Description Founded Year Domain Location
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
Founded Year Domain Location
Startup ecosystems are ignited through strategic investments by Signite Partners.
Founded Year Domain Location
Venture capital is directed toward companies in multiple sectors.
Founded Year Domain Location
Venture capital is invested in cybersecurity, fintech, and AI startups.
Founded Year Domain Location

Investments & Acquisitions by Vernal

Investments
Company Name Description Domain Location Founded Year Amount
Bionic investment advisor platform
2016
Fine Asian gourmet food is offered by an internet-first restaurant.
2016
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
2014
Fine Asian gourmet food is offered by an internet-first restaurant.
2016

Financial Statements - Vernal

Tata Steel revenue growth over time
Tata Steel profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Jan, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Vernal Comparisons

Employees
+
Add Comparison
Available on Premium

Competitors of Vernal

Vernal operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Aqemia, NTxBio, Nimble Therapeutics, Applied BioMath and IMIDomics, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.

Company Name Domain Founded year HQ Location Description
domain founded_year HQ Location
Therapeutic molecules are discovered through AI and quantum physics integration.
domain founded_year HQ Location
Provider of bio informatics platform to develops biologics and therapeutics
domain founded_year HQ Location
Combinatorial chemistry services for peptide-based drug discovery are provided.
domain founded_year HQ Location
Systems biology and pharmacology modeling services to aid drug discovery and development
domain founded_year HQ Location
Precision medicines for immune-mediated inflammatory diseases are developed.
domain founded_year HQ Location
Software solutions for computational chemistry are developed and provided.
Company Name Domain Founded year HQ Location Description
domain founded_year HQ Location
Multiple services are booked via an app-based platform.
domain founded_year HQ Location
On-demand services are booked through an app-based platform.
domain founded_year HQ Location
App based platform offering on demand delivery and ride-hailing services
domain founded_year HQ Location
Operates an on-demand hyperlocal delivery app for food and groceries.

Latest news on Vernal

PE-backed Orion buys Vernalis
Pehub8 years ago

Frequently Asked Questions about Vernal

When was Vernal founded?

Vernal was founded in 2010.

Where is Vernal located?

Vernal is headquartered in New York, United States. It is registered at New York, New York, United States.

What does Vernal do?

Vernalis was founded in 2010 and is headquartered in New York, United States. Operations focus on the biotechnology sector, where a specialized platform for fragment and structure-based drug discovery is utilized. Services encompass early-stage research tools and methodologies to support pharmaceutical development. The company operates primarily in the United States, aiding clients in identifying potential drug candidates through advanced structural analysis techniques.

Who are the top competitors of Vernal?

Vernal's top competitors include Aqemia, NTxBio and Enveda.

Who are Vernal's investors?

Vernal has 2 investors. Key investors include Orioninc, and Potomac Equity Partners.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available